Blog

As a sense of dread spreads across America around the COVID-19 pandemic, the impact on those struggling with substance use disorder (SUD) is even more significant, yet relatively unacknowledged. Fear

The social distancing and quarantine orders in place across the land are effective in slowing the spread of coronavirus, but the destructive consequence is that they unravel the very support

One of the best ways to reduce isolation during a time of crisis is through SUD technology such as the Connections smartphone app, a part of the CHESS Health Platform

Opioid deaths, addiction, and misuse of prescription drugs continue to be significant issues for communities across the country. The good news is that we are making progress. Besides additional support

Thinking of applying? CHESS can help The National Council for Behavioral Health recently sent out an email blast to spread word of a funding opportunity announcement from the Substance Abuse

The Massachusetts Department of Correction press release announces more than $1.2 million in federal funds intended to “treat opioid use disorder among inmates effectively and humanely . . . “

People deserve compassionate, evidence-based care that reflects the chronic and unique nature of this illness

Leveraging Peer Specialists and Patient Engagement Tools Prior to Discharge Helps Establish a More Successful Recovery Journey

Confronting Substance Use Disorder (SUD) Takes a Deft Mix of Traditional Therapeutic Models and New Technologies

Those who work in the Substance Use Disorder treatment community will likely find Kathleen Hannigan’s observation relevant – especially when the discussion turns to the best way to incorporate technology

Reducing Gaps in Information is Key to Treatment Success The latest statistics from the CDC indicate 63,632 Americans died in 2016 from drug overdose, 66% of which were related to

A new approach to enabling more effective treatment programs to achieve long-term recovery success. Patients struggling with substance us disorders (SUD) affects an estimated 320 million people worldwide.1 In 2016